France vs Sierra Leone: Access to anti-retroviral drugs, female
France
93.0%
in 2022
Sierra Leone
95.0%
in 2024
France rank
22nd
Sierra Leone rank
19th
Access to anti-retroviral drugs, female over time
- France
- Sierra Leone
How they compare
Sierra Leone currently reports 95.0% against 93.0% in France, a difference of 2.0%.
Across all 23 years both countries report, France has been ahead every year.
France ranks 22nd and Sierra Leone ranks 19th of 141 countries.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | France | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 81.2% | 1.5% | 79.7% | France |
| 2010s | 90.4% | 28.4% | 62.0% | France |
| 2020s | 91.7% | 73.0% | 18.7% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, France or Sierra Leone?
- Sierra Leone, at 95.0% against 93.0% in France as of 2024.
- What is the difference in access to anti-retroviral drugs, female between France and Sierra Leone?
- 2.0%, with Sierra Leone ahead.
- How many years of comparable data are there for France and Sierra Leone?
- 23 years are reported by both, from 2000 to 2022.
- How do France and Sierra Leone rank globally for access to anti-retroviral drugs, female?
- France ranks 22nd and Sierra Leone ranks 19th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.